ALAB vs RMBS
Astera Labs vs Rambus — AI-powered side-by-side comparison
| Metric | ALAB | RMBS |
|---|
| AI Score |
62
|
64
|
| Price |
$334.03
|
$101.41
|
| P/E Ratio |
154.00×
|
45.73×
|
| ROE |
16.1%
|
16.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
75.1%
|
78.3%
|
| Debt / Equity |
0.00×
|
0.01×
|
| Dividend Yield |
0.0%
|
0.0%
|
| RSI (14) |
54.2
|
57.4
|
| Beta |
3.671
|
1.84
|
| Expected Upside |
+49.3%
|
+7.5%
|
AI Committee View
Current Innellis committee reasoning for ALAB versus RMBS.
RMBS leads by 2 points.
RMBS scores 64/100 (Buy) versus ALAB at 62/100 (Buy).
ALAB Committee View
60% agreement
5 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — 5 consecutive earnings beats -- consistent execution. Risk Analyst remains cautious — bollinger bandwidth of 39.0% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Bollinger bandwidth of 39.0% signals elevated volatility — Risk
RMBS Committee View
67% agreement
6 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is p/e of 45.9 is expensive by classic value standards. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 17.4% shows genuine earnings power backing the valuation — Value
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- P/E of 45.9 is expensive by classic value standards — Value
- Price-to-book of 7.2x prices in significant intangible value — Value
- Bollinger bandwidth of 25.9% signals elevated volatility — Risk